期刊文献+

重症肌无力的中西医治疗进展 被引量:6

Progress review of the treatment of myasthenia gravis with Chinese and western medicine
暂未订购
导出
摘要 重症肌无力是一种由抗体参与,神经肌肉传导失调的疾病。临床表现从单纯仅累及眼肌到威胁生命而出现呼吸不足的肌无力危象。本病有病理生理学的改变,出现乙酰胆碱受体或抗MuSK抗体的存在或缺乏以及胸腺瘤的存在。乙酰胆碱酯酶抑制剂可以暂时缓解症状,但是绝大多数患者接受了免疫治疗。中医中药的治疗也取得了良好的效果。重症肌无力的死亡率在20世纪明显减少,但是治疗的副作用、患者的护理以及严格的治疗指南还依然不明确。 Myasthenia gravis is an antibody involved neuromuscular disorder. Clinical manifestations include myasthenic crisis involving only the eye muscle to life-threatening respiratory insufficiency. The disease has pathophysiological changes, with the presence or absence of acetylcholine receptor or anti-MuSK antibodies and the presence of thymoma. Acetylcholinesterase inhibitors can relieve symptoms temporarily, but the vast majority of patients have to receive immunotherapy. Traditional Chinese medicine treatment has also achieved good results. In the 20th century, the mortality of myasthenia gravis decreased significantly, but the side effects of treatment, patient care and strict treat- ment guidelines are still not clear yet.
出处 《中国医药导报》 CAS 2013年第7期27-29,共3页 China Medical Herald
关键词 重症肌无力 治疗 西医 中医 Myasthenia gravis Treatment Western medicine Traditional Chinese medicine
  • 相关文献

参考文献25

  • 1Pascuzzi RM. The history of myasthenia gravis [J]. Neurol Clin, 1994,12 (2) :231-242.
  • 2Maggi L, Mantegazza R. Treatment of myasthenia gravis focus on pyri- dostlgmine [J]. Clin Drug Investig, 2011,31 ( 10 ) : 691-701.
  • 3Mehndiratta MM ,Pandey S,Kuntzer T. Acetylcholinesterase inhibitor treatment for myasthenia gravis [J]. Cochrane Database Syst Rev, 2011, (2) :CD006986.
  • 4Sieb JP, Kohler W. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis:resuhs of a prospective muhicenter open-label trial [J]. Clin Neurol Neurosurg,2010,112(9):781-784.
  • 5Yu QS,Holloway HW,Luo W,et al. Long-acting anticholinesterases for myasthenia gravis:synthesis and activities of quaternary phenyl- carbamates of neostigmine,pyridostigmine and physostigmine [J]. Bioorg Med Chem, 2010,18 ( 13 ) :4687-4693.
  • 6Gilhus NE,Owe JF,Hoff JM,et al. Myasthenia gravis :a review of avail- able treatment approaches [J]. Autoimmune Dis,2011,2011 (2011 ) :847 393.
  • 7Kawaguchi N. Immunosuppressive/immunomodulating therapies in myasthenia gravis-at present and in the near future [J]. Brain Nerve, 2011,63(7) :737-743.
  • 8Fattorossi A, Battaglia A,Buzzonetti A,et al. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis:effect of immuno- suppressive treatment [J]. Immunology ,2005,116( 1 ) : 134-141.
  • 9刘汝宏,丛志强,钟孟飞,王海萍,李江,陈晓辉.重症肌无力患者免疫治疗过程中sIL-6R的动态演变[J].中风与神经疾病杂志,2011,28(8):724-727. 被引量:1
  • 10康晓萍,黄志.糖皮质激素对重症肌无力患儿T细胞亚群、体液免疫的调控及其干预作用[J].实用儿科临床杂志,2010,25(18):1419-1421. 被引量:6

二级参考文献51

共引文献83

同被引文献48

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33100
  • 2涂来慧,蒋建明,吴涛.重症肌无力[M].上海:第二军医大学出版社,2010.10.
  • 3Car AS,Cardwell CR,McCarron PO,et al.A systematic review of population based epidemiological studies in Myasthenia Gravis[J].BMC Neurol,2010,10:46.
  • 4Gilhus NE.Autoimmune myasthenia gravis[J].Expert Rev Neurother,2009,9(3):351-358.
  • 5Evoli A,Bianchi MR,Riso R,et al.Response to therapy in myasthenia gravis with anti-MuSK antibodies[J].Ann NYAcad Sic,2008,1132:76-83.
  • 6中国免疫学会神经免疫分会,中华医学会神经病学分会神经免疫学组.中国重症肌无力诊断和治疗专家共识[J].中国神经免疫学和神经病学杂志,2012,19(6):401-408.
  • 7Cuptill JT,Sanders DB.Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis[J].Curr Opin Neurol,2010,23(5):530-535.
  • 8Berrih-Aknin S,Ragheb S,Le Panse R,et al.Ectopic germinal centers,BAFF and anti-B-cell therapy in myasthenia gravis[J].Autoimmun Rev,2013,12(9,SI):885-893.
  • 9Kupersmith MJ.Ocular myasthenia gravis:treatment successes and failures in patients with long term follow up[J].Neurology,2009,72(11):A440-A441.
  • 10Pedersen E,Pottegaard A,Hallas J,et al.Use of azathioprine for NonThymoma myasthenia and risk of cancer:a nationwide Case-Control study in Denmark[J].Neurology,2013,80(S):942-948.

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部